Prevention and reversal of lipotoxicity-induced hepatic insulin resistance and steatohepatitis in mice by an antioxidant carotenoid, β-cryptoxanthin

Endocrinology (United States)

Volumn 156, Issue 3, 2015, Pages 987-999

  Ni, Yinhua ^a,b   Nagashimada, Mayumi ^a   Zhan, Lili ^a   Nagata, Naoto ^a   Kobori, Masuko ^c   Sugiura, Minoru ^d   Ogawa, Kazunori ^d   Kaneko, Shuichi ^b   Ota, Tsuguhito ^a,b  

^a KANAZAWA UNIVERSITY   (Japan)

^b KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^c NATIONAL FOOD RESEARCH INSTITUTE   (Japan)

^d NATIONAL INSTITUTE OF FRUIT TREE SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CRYPTOXANTHIN; GLUCOSE; INSULIN; ANTIOXIDANT; CRYPTOXANTHIN; FAT INTAKE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CHOLESTEROL DIET; FLOW CYTOMETRY; GENE EXPRESSION; GLUCOSE HOMEOSTASIS; IMMUNOHISTOCHEMISTRY; INSULIN RESISTANCE; KUPFFER CELL; LIPID DIET; LIPID LIVER LEVEL; LIPID PEROXIDATION; LIPOTOXICITY; LIVER CELL; LIVER FIBROSIS; MACROPHAGE; MACROPHAGE ACTIVATION; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; STELLATE CELL; ADMINISTRATION AND DOSAGE; ADVERSE EFFECTS; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; DRUG EFFECTS; FAT INTAKE; HOMEOSTASIS; LIVER; LIVER CIRRHOSIS; METABOLISM; OBESITY; PATHOLOGY;

ANIMALS; ANTIOXIDANTS; CRYPTOXANTHINS; DIETARY FATS; GLUCOSE; HEPATIC STELLATE CELLS; HOMEOSTASIS; INSULIN RESISTANCE; KUPFFER CELLS; LIVER; LIVER CIRRHOSIS; MALE; MICE; MICE, INBRED C57BL; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY;

EID: 84923884829     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2014-1776     Document Type: Article

References (30)

1. DeFronzo RA. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. Diabetologia. 2010;53(7):1270-1287.
2. Cusi K.Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications. Gastroenterology. 2012;142(4):711-725.e716.
3. Matsuzawa N, Takamura T, Kurita S, et al. Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet. Hepatology. 2007;46(5):1392-1403.
4. Sanyal AJ, Chalasani N, Kowdley KV, et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med. 2010; 362(18):1675-1685.
5. Leo MA, Rosman AS, Lieber CS. Differential depletion of carotenoids and tocopherol in liver disease. Hepatology. 1993;17(6):977-986.
6. Yadav D, Hertan HI, Schweitzer P, Norkus EP, Pitchumoni CS. Serum and liver micronutrient antioxidants and serum oxidative stress in patients with chronic hepatitis C. Am J Gastroenterol. 2002; 97(10):2634-2639.
7. Ruhl CE, Everhart JE. Relation of elevated serum alanine aminotransferase activity with iron and antioxidant levels in the United States. Gastroenterology. 2003;124(7):1821-1829.
8. Neuhouser ML, Rock CL, Eldridge AL, et al. Serum concentrations of retinol, α-tocopherol and the carotenoids are influenced by diet, race and obesity in a sample of healthy adolescents. J Nutr. 2001; 131(8):2184-2191.
9. Gunanti IR, Marks GC, Al-Mamun A, Long KZ. Low serum concentrations of carotenoids and vitamin E are associated with high adiposity in Mexican-American children. J Nutr. 2014;144(4):489-495.
10. Rock CL, Jacob RA, Bowen PE. Update on the biological characteristics of the antioxidant micronutrients: vitamin C, vitamin E, and the carotenoids. J Am Diet Assoc. 1996;96(7):693-702; quiz 703-694.
11. Sugiura M, Nakamura M, Ikoma Y, Yano M, et al. The homeostasis model assessment-insulin resistance index is inversely associated with serum carotenoids in non-diabetic subjects. J Epidemiol. 2006; 16(2):71-78.
12. Sugiura M, Nakamura M, Ikoma Y, et al. High serum carotenoids are inversely associated with serum γ-glutamyltransferase in alcohol drinkers within normal liver function. J Epidemiol. 2005;15(5):180-186.
13. Haegele AD, Gillette C, O'Neill C, et al. Plasma xanthophyll carotenoids correlate inversely with indices of oxidative DNA damage and lipid peroxidation. Cancer Epidemiol Biomarkers Prev. 2000; 9(4):421-425.
14. Katsuura S, Imamura T, Bando N, Yamanishi R. β-Carotene and β-cryptoxanthin but not lutein evoke redox and immune changes in RAW264 murine macrophages. Mol Nutr Food Res. 2009;53(11):1396-1405.
15. Kobori M, Ni Y, Takahashi Y, et al. β-Cryptoxanthin alleviates diet-induced nonalcoholic steatohepatitis by suppressing inflammatory gene expression in mice. PLoS One. 2014;9(5):e98294.
16. Ogawa K, Ozaki Y, Sugiura M. Refining of β-cryptoxanthin from the extract of Satsuma mandarin by-products using component solvent solubility differences. Nippon Shokuhin Kagaku Kogaku Kaishi. 2013;60:498-508.
17. Kitade H, Sawamoto K, Nagashimada M, et al. CCR5 plays a critical role in obesity-induced adipose tissue inflammation and insulin resistance by regulating both macrophage recruitment and M1/M2 status. Diabetes. 2012;61(7):1680-1690.
18. Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus:NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002;30(1):207-210.
19. Kimura K, Yamada T, Matsumoto M, et al. Endoplasmic reticulum stress inhibits STAT3-dependent suppression of hepatic gluconeogenesis via dephosphorylation and deacetylation. Diabetes. 2012; 61(1):61-73.
20. Ota T, Gayet C, Ginsberg HN. Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents. J Clin Invest. 2008;118(1):316-332.
21. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004;25(12):677-686.
22. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest. 2007;117(1):175-184.
23. Moore KJ, Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell. 2011;145(3):341-355.
24. Wan J, Benkdane M, Teixeira-Clerc F, et al. M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease. Hepatology. 2014;59(1):130-142.
25. Sutti S, Jindal A, Locatelli I, et al. Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH. Hepatology. 2014;59(3):886-897.
26. Swirski FK, Libby P, Aikawa E, et al. Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J Clin Invest. 2007;117(1):195-205.
27. Nahrendorf M, Swirski FK, Aikawa E, et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med. 2007;204(12):3037-3047.
28. Sugiura M, Ogawa K, Yano M. Comparison of bioavailability between β-cryptoxanthin and β-carotene and tissue distribution in its intact form in rats. Biosci Biotechnol Biochem. 2014;78(2):307-310.
29. Chung MY, Yeung SF, Park HJ, Volek JS, Bruno RS. Dietary α- and γ-tocopherol supplementation attenuates lipopolysaccharide-induced oxidative stress and inflammatory-related responses in an obese mouse model of nonalcoholic steatohepatitis. The J Nutrit Biochem. 2010;21(12):1200-1206.
30. Matsumoto A, Mizukami H, Mizuno S, et al. β-Cryptoxanthin, a novel natural RAR ligand, induces ATP-binding cassette transporters in macrophages. Biochem Pharmacol. 2007;74(2):256-264.